GL1X · GenesisL1 explorer

MolNFT v1 · #68670 · protein

Crystal structure of eonyl-(acyl-carrier-protein) reductase from anaplasma phagocytophilum in complex with NAD at 1.9A resolution

3K31 · Enoyl-(acyl-carrier-protein) reductase: “Crystal structure of eonyl-(acyl-carrier-protein) reductase from anaplasma phagocytophilum in complex with…”. X-ray diffraction, 1 ligand (NAD), 5 pockets (best druggability 0.73). MolNFT v1…

PDB
3K31
Type
protein
Length
522 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-(acyl-carrier-protein) reductase
EC
1.3.1.9
UniProt
Q2GKM8
Ligands
NAD
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-(acyl-carrier-protein) reductase (EC 1.3.1.9)protein26248% helix, 15% strandQ2GKM8
BEnoyl-(acyl-carrier-protein) reductase (EC 1.3.1.9)protein26049% helix, 15% strandQ2GKM8

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B
  • GOL · Glycerol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17120.730.7950NAD, EDO
25490.650.7648empty
31620.480.7721empty
4680.430.8018empty
5540.400.8116empty

Interfaces

1 interface between chains.

  • A–B · 1557 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 3K31 · Crystal structure of eonyl-(acyl-carrier-protein) reductase from anaplasma… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.